High Wnt2B and Wnt11 expression indicates poor outcomes, while high Wnt10A expression indicates good outcomes in AML patients with chemotherapy alone, but they have no prognostic significance in AML patients receiving allo‐HSCT. Here, WNT11 is linked to acute myeloid leukemia.